Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The therapeutic potential of nanoscale sphingolipid technologies.
Handb Exp Pharmacol. 2013;(215):197-210. doi: 10.1007/978-3-7091-1368-4_11.
Handb Exp Pharmacol. 2013.
PMID: 23579457
Review.
C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia.
Ryland LK, Doshi UA, Shanmugavelandy SS, Fox TE, Aliaga C, Broeg K, Baab KT, Young M, Khan O, Haakenson JK, Jarbadan NR, Liao J, Wang HG, Feith DJ, Loughran TP Jr, Liu X, Kester M.
Ryland LK, et al. Among authors: doshi ua.
PLoS One. 2013 Dec 19;8(12):e84648. doi: 10.1371/journal.pone.0084648. eCollection 2013.
PLoS One. 2013.
PMID: 24367685
Free PMC article.
Item in Clipboard
STAT3 mediates C6-ceramide-induced cell death in chronic lymphocytic leukemia.
Doshi UA, Shaw J, Fox TE, Claxton DF, Loughran TP, Kester M.
Doshi UA, et al.
Signal Transduct Target Ther. 2017 Oct 27;2:17051. doi: 10.1038/sigtrans.2017.51. eCollection 2017.
Signal Transduct Target Ther. 2017.
PMID: 29263930
Free PMC article.
Item in Clipboard
Cite
Cite